Mpox in assisted conception: should we be worried about this monkey wrench?
Michael B Yakass1,2, Bryan J Woodward3
1The Fertility Centrum, IVF Clinics, Accra, Ghana.
Human Fertility (Cambridge, England)
|December 16, 2024
Summary
Mpox virus (MPXV) in semen poses risks to fertility specialists. This commentary outlines MPXV information and vigilance steps for handling reproductive samples from infected individuals.
Area of Science:
- Virology
- Reproductive Medicine
- Public Health
Background:
- Mpox virus (MPXV) outbreaks have led to a global health emergency declaration by the WHO.
- MPXV has been detected in the semen of infected individuals, presenting a potential occupational hazard.
- Healthcare professionals in medically assisted reproduction (MAR) clinics are at risk due to handling infectious samples.
Purpose of the Study:
- To provide essential information regarding MPXV.
- To highlight critical vigilance and safety measures for MAR professionals.
- To address the risks associated with processing reproductive materials from MPXV-infected persons.
Main Methods:
- This is a commentary, not an experimental study.
- Information synthesis on MPXV transmission and detection in reproductive samples.
- Review of current public health recommendations and expert insights.
Main Results:
- MPXV presence in semen is confirmed, necessitating heightened awareness.
- Clinical embryologists and andrologists face direct exposure risks.
- Standard laboratory protocols may require adaptation to mitigate MPXV transmission.
Conclusions:
- Vigilance in handling semen, oocytes, pre-implantation embryos, and managing pregnancies is crucial.
- MAR clinics must implement specific safety protocols to protect staff and patients.
- Proactive risk assessment and management are essential during MPXV outbreaks.


